- Home - SOFIE
SOFIE Biosciences opens PET Manufacturing Facility, expanding service in Illinois, Missouri, and Indiana
- Who We Are - SOFIE
With our premier radiopharmacy network, mature contract manufacturing services and high value theranostic intellectual property, SOFIE is dedicated to improving patient health MEET OUR TEAM FROM START TO CLINIC
- Focus on FAPI Newsletter - Spring 2025 - SOFIE
SOFIE is continuing to accept applications for our FAPI Outreach Program This program aims to raise awareness and foster collaboration in the field of molecular imaging, specifically focusing on Fibroblast Activation Protein Inhibitor (FAPI) studies
- SOFIE network expands production of 18F-FAPI-74 - SOFIE
Thanks to the diligent efforts of our team, 18F-FAPI-74 production is now live at FIVE sites in SOFIE’s network – Totowa, NJ; Gilroy, CA; Romeoville, IL; Sanford, FL, and Cleveland, OH Most of these activations took place in 2024 with additional sites planned for 2025
- Trilantic North America Completes Strategic Growth Investment . . . - SOFIE
NEW YORK (June 4, 2024) – Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences ("SOFIE" or the "Company"), a founder-led radiopharmacy and contract development and manufacturing organization
- Network - SOFIE
SOFIE has built a high-capacity PET radiopharmaceutical network capable of delivering large volumes of products to as many patients as possible Our product lines include FDG, Pylarify, Neuraceq, and other clinical trial products
- Focus on FAPI Newsletter - Winter 2025 - SOFIE
SOFIE is continuing to accept applications for our FAPI Outreach Program This program aims to raise awareness and foster collaboration in the field of molecular imaging, specifically focusing on Fibroblast Activation Protein Inhibitor (FAPI) studies
- Access - SOFIE
SOFIE has engaged with many academic institutions globally to unlock FAPI’s clinical utility potential We are pleased to support your interest in the use of FAPI as a diagnostic or companion diagnostic tool
|